Mondelez International, Inc.

Analysis of Mondelez International (MDLZ)

Technical Analysis MDLZ exhibits strong positive momentum with impressive gains of over 11% in three months, significantly outpacing the market. Trading 12% below its 52-week high, the stock is not yet overextended, suggesting room for continued upward movement. Its low beta indicates stability, making it an attractive option for risk-conscious investors.

Fundamentals Revenue growth and improved profitability highlight Mondelez’s operational strength, though modest ROE and low asset turnover reflect sector norms. The company maintains solid debt management and efficient working capital, but weak liquidity ratios warrant monitoring. Overall, fundamentals support steady performance despite sector-wide inefficiencies.

Valuation MDLZ appears overvalued with a high PE ratio and negative PEG, indicating premium pricing unsupported by growth. Compared to typical consumer staples peers, its elevated EV/EBITDA suggests limited margin for error. Investors should weigh these metrics carefully against the company’s stable earnings trajectory.

Risk Assessment With low market volatility and negligible short interest, MDLZ faces minimal speculative risk. However, its substantial past drawdown underscores vulnerability to sector-specific headwinds like inflation or competitive pressures. The stock’s defensive nature partially offsets these concerns.

---

Investment Recommendation

MDLZ presents a compelling case for investors seeking stability with growth potential. Its technical strength, reinforced by solid revenue expansion and efficient operations, supports bullish sentiment despite premium valuation. While the high PE ratio warrants caution, the stock’s defensive qualities and consistent performance justify consideration for a diversified portfolio. For long-term investors, MDLZ represents a quality holding in the consumer staples sector.

*Note: This is not investment advice, for reference only.*

RockFlow Model Forecast: Three Scenarios for 2026

Based on the provided analysis, here is a 12-month outlook for Mondelez International (MDLZ):

MDLZ's outlook is supported by key catalysts including its strong revenue growth, operational efficiency, and defensive qualities that should continue to attract investors seeking stability. The stock's positive momentum and distance from its 52-week high suggest there is room for further appreciation, particularly if the company can maintain its earnings trajectory. Potential risks primarily stem from its premium valuation (high PE ratio, negative PEG), which leaves little margin for error if the company faces sector headwinds like inflationary pressures or competitive challenges that impact profitability. Given the lack of a specific analyst target, a reasonable 12-month target price range would be in the mid-to-high $60s, contingent on the company successfully navigating its valuation concerns while delivering on its steady operational performance.

Wall Street Consensus

Most Wall Street analysts are optimistic about Mondelez International, Inc.'s 12-month outlook, with consensus target around $62.59, indicating expected upside potential.

Overall, MDLZ has investment potential but also faces challenges. Here are key factors to weigh before investing.

MDLZ has demonstrated strong positive momentum across multiple timeframes, significantly outperforming the broader market. The stock has exhibited substantial gains while maintaining lower volatility than the market, as evidenced by its low beta.

Over the past one and three months, MDLZ has delivered impressive returns of 9.37% and 11.27% respectively, substantially outperforming the market by 11.22% over the three-month period. This suggests strong relative strength and positive investor sentiment toward the stock in the near term.

Currently trading at $62.59, MDLZ sits approximately 56% above its 52-week low but remains 12% below its 52-week high, positioning it in the upper-middle range of its yearly trading band. Despite the strong recent performance, the stock does not appear overextended given its significant distance from the yearly peak and its substantial maximum drawdown of -27.19% over the past year.

Revenue & Profitability: Mondelez delivered stronger Q4 revenue of $10.5 billion, up from $9.7 billion in Q3, demonstrating solid top-line growth. Profitability improved with the operating income margin expanding to 9.3% from 7.6%, driven by an improved gross profit margin of 28.2%. The net income ratio of 6.3% reflects effective cost management despite a significant 28% effective tax rate in the quarter.

Financial Health: The company maintains a moderate debt profile with a manageable debt-to-equity ratio of 0.87 and a healthy interest coverage ratio of 18.1x. However, liquidity appears constrained with weak current and quick ratios of 0.59 and 0.39 respectively, though the negative cash conversion cycle of -26.6 days indicates efficient working capital management that generates cash from operations.

Operational Efficiency: Operational returns are modest with an ROE of 2.6% and ROA of 0.9%, suggesting room for improvement in capital allocation effectiveness. Asset turnover remains low at 0.15, characteristic of the capital-intensive consumer staples sector, while the inventory turnover of 1.7 reflects typical inventory cycles for perishable food products.

Of course. Here is the valuation analysis for MDLZ based on the provided metrics.

Valuation Level

Based on the trailing PE ratio of 32.53 and a forward PE of 26.09, MDLZ appears significantly overvalued on an absolute basis. A PE in this range typically indicates a high growth expectation, which is starkly contradicted by the highly negative PEG ratio of -2.97, suggesting the market's earnings growth expectations are not being met or that earnings are declining. This negative PEG, coupled with an exceptionally high EV/EBITDA of 67.67, signals that the company's enterprise value is very expensive relative to its core operating cash flow, further supporting a conclusion of overvaluation.

Peer Comparison

Without specific industry averages for a direct comparison, a general assessment can be made. A PE ratio above 30 is generally considered high for a mature consumer staples company, which typically trade at lower multiples due to stable but slow growth. Similarly, an EV/EBITDA multiple of nearly 68 is extremely elevated compared to broad market or consumer staples norms, which often range from the low to mid-teens. The negative PEG ratio is a significant outlier, as a healthy valuation typically features a positive PEG below 1, indicating that MDLZ's valuation premiums are not justified by its growth profile relative to the sector.

Volatility Risk: MDLZ exhibits low volatility risk relative to the broader market, as evidenced by its Beta of 0.40, indicating it is significantly less volatile. However, the stock experienced a notable 1-year maximum drawdown of -27.19%, suggesting it is still susceptible to substantial downside movements during market downturns or company-specific negative catalysts.

Other Risks: MDLZ faces minimal risk from short-term speculative pressures, as indicated by the absence of significant short interest. Potential risks are more likely to stem from fundamental factors such as input cost inflation, competitive pressures in the packaged foods industry, or shifts in consumer preferences, while its high liquidity ensures orderly trading.